RU97120751A - METHOD FOR OBTAINING ROPIVACAININE MONOHYDRATE OF HYDROCHLORIDE AND ROPIVACAINE HYDROCHLORIDE MONOHYDRATE OBTAINED BY THIS METHOD - Google Patents
METHOD FOR OBTAINING ROPIVACAININE MONOHYDRATE OF HYDROCHLORIDE AND ROPIVACAINE HYDROCHLORIDE MONOHYDRATE OBTAINED BY THIS METHODInfo
- Publication number
- RU97120751A RU97120751A RU97120751/04A RU97120751A RU97120751A RU 97120751 A RU97120751 A RU 97120751A RU 97120751/04 A RU97120751/04 A RU 97120751/04A RU 97120751 A RU97120751 A RU 97120751A RU 97120751 A RU97120751 A RU 97120751A
- Authority
- RU
- Russia
- Prior art keywords
- stage
- base
- formula
- water
- hydrochloride
- Prior art date
Links
- VSHFRHVKMYGBJL-CKUXDGONSA-N (S)-ropivacaine hydrochloride hydrate Chemical compound O.[Cl-].CCC[NH+]1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C VSHFRHVKMYGBJL-CKUXDGONSA-N 0.000 title claims 4
- 229960003691 ROPIVACAINE HYDROCHLORIDE MONOHYDRATE Drugs 0.000 title claims 2
- 150000004682 monohydrates Chemical class 0.000 title claims 2
- DKAGJZJALZXOOV-UHFFFAOYSA-N hydrate;hydrochloride Chemical compound O.Cl DKAGJZJALZXOOV-UHFFFAOYSA-N 0.000 title 1
- CSCPPACGZOOCGX-UHFFFAOYSA-N acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 7
- 239000003153 chemical reaction reagent Substances 0.000 claims 5
- 238000000605 extraction Methods 0.000 claims 5
- 239000003960 organic solvent Substances 0.000 claims 5
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims 5
- 239000003054 catalyst Substances 0.000 claims 4
- 238000006243 chemical reaction Methods 0.000 claims 4
- 238000002425 crystallisation Methods 0.000 claims 4
- 230000005712 crystallization Effects 0.000 claims 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N HCl Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 3
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M Sodium iodide Chemical group [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 claims 3
- 150000002576 ketones Chemical class 0.000 claims 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- 239000011780 sodium chloride Substances 0.000 claims 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims 3
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 claims 2
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 claims 2
- 229960001813 Ropivacaine hydrochloride Drugs 0.000 claims 2
- WEVYAHXRMPXWCK-UHFFFAOYSA-N acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 2
- 229910000041 hydrogen chloride Inorganic materials 0.000 claims 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N n-butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims 2
- 239000001184 potassium carbonate Substances 0.000 claims 2
- 229910000027 potassium carbonate Inorganic materials 0.000 claims 2
- VLYFRFHWUBBLRR-UHFFFAOYSA-L potassium;sodium;carbonate Chemical compound [Na+].[K+].[O-]C([O-])=O VLYFRFHWUBBLRR-UHFFFAOYSA-L 0.000 claims 2
- YXFVVABEGXRONW-UHFFFAOYSA-N toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims 2
- ZMANZCXQSJIPKH-UHFFFAOYSA-N triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims 2
- LKKUYGGQEIJGDR-UHFFFAOYSA-N 1-iodopropane Chemical compound [CH2]CCI LKKUYGGQEIJGDR-UHFFFAOYSA-N 0.000 claims 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate dianion Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims 1
- CYNYIHKIEHGYOZ-UHFFFAOYSA-N N-Propyl bromide Chemical compound CCCBr CYNYIHKIEHGYOZ-UHFFFAOYSA-N 0.000 claims 1
- 229940083599 Sodium Iodide Drugs 0.000 claims 1
- 230000002152 alkylating Effects 0.000 claims 1
- 238000005804 alkylation reaction Methods 0.000 claims 1
- 150000001412 amines Chemical class 0.000 claims 1
- 238000009835 boiling Methods 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 238000010438 heat treatment Methods 0.000 claims 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-M iodide Chemical compound [I-] XMBWDFGMSWQBCA-UHFFFAOYSA-M 0.000 claims 1
- 235000009518 sodium iodide Nutrition 0.000 claims 1
- 239000007858 starting material Substances 0.000 claims 1
Claims (21)
•HCl•H2O
отличающийся тем, что он включает следующие стадии реакции:
стадия 1 (i) рацемическое исходное вещество - пипеколоксилидид гидрохлорид формулы II
освобождают от НСl, образующий с ним соль, путем экстракции в органическом растворителе, содержащем разбавленное основание; (ii) пипеколоксилидид разделяют путем кристаллизации с разделяющим реагентом, образующим стабильную кристаллизационную систему с водой, и кристаллический продукт выделяют из его соли путем экстракции и органическом растворителе, который растворяет минимум около 1 мас.% воды, с разбавленным основанием, и получают соединение (S)- пипеколоксилидид формулы III
стадия 2 (i) (S) - пипеколоксилидид формулы (III) алкилируют 1-галогенпропаном в присутствии основания и, необязательно, в присутствии катализатора, причем реакция проводится при нагревании, после чего неорганические соли удаляют путем экстракции водой; (ii) раствор, полученный на стадии 2 (i), необязательно разбавляют, и осаждают продукт в виде ропивакаина гидрохлорида формулы IV
который затем выделяют;
стадия 3 продукт (IV), полученный на стадии 2 (ii), растворяют в водном ацетоне, осаждают продукт (1) путем добавления ацетона, и этот продукт окончательно выделяют и сушат.1. The method of obtaining monohydrate of ropivacaine hydrochloride of formula I
• HCl • H 2 O
characterized in that it comprises the following reaction steps:
Stage 1 (i) racemic starting material - pipecoloxylidide hydrochloride of formula II
free from HCl, which forms a salt with it, by extraction in an organic solvent containing a dilute base; (ii) pipecoloxidide is separated by crystallization with a separating reagent, forming a stable crystallization system with water, and the crystalline product is separated from its salt by extraction and an organic solvent that dissolves at least about 1% by weight of water, with a dilute base, and a compound (S ) - pipecoloxidate formula III
Step 2 (i) (S) - Pipecoloxylidide of formula (III) is alkylated with 1-halopropane in the presence of a base and, optionally, in the presence of a catalyst, the reaction is carried out with heating, after which the inorganic salts are removed by extraction with water; (ii) the solution obtained in step 2 (i) is optionally diluted, and the product precipitated as ropivacaine hydrochloride of formula IV
which is then isolated;
stage 3, the product (IV) obtained in stage 2 (ii) is dissolved in aqueous acetone, the product (1) is precipitated by the addition of acetone, and this product is finally isolated and dried.
полученный согласно способу по п.1.21. Ropivacaine hydrochloride monohydrate of the formula I
obtained according to the method according to claim 1.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9501808-1 | 1995-05-16 | ||
SE9501808A SE9501808D0 (en) | 1995-05-16 | 1995-05-16 | New process |
Publications (2)
Publication Number | Publication Date |
---|---|
RU97120751A true RU97120751A (en) | 1999-09-20 |
RU2167153C2 RU2167153C2 (en) | 2001-05-20 |
Family
ID=20398325
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU97120751/04A RU2167153C2 (en) | 1995-05-16 | 1996-04-30 | Method of synthesis of ropivacaine hydrochloride monohydrate |
Country Status (34)
Country | Link |
---|---|
US (1) | US5959112A (en) |
EP (1) | EP0828711B1 (en) |
JP (1) | JP3079112B2 (en) |
KR (1) | KR100425232B1 (en) |
CN (1) | CN1121388C (en) |
AR (1) | AR002737A1 (en) |
AT (1) | ATE207900T1 (en) |
AU (1) | AU696875B2 (en) |
BR (1) | BR9608820A (en) |
CA (1) | CA2219308C (en) |
CZ (1) | CZ290576B6 (en) |
DE (1) | DE69616543T2 (en) |
DK (1) | DK0828711T3 (en) |
EE (1) | EE03394B1 (en) |
ES (1) | ES2166888T3 (en) |
HK (1) | HK1009805A1 (en) |
HU (1) | HU221793B1 (en) |
IL (1) | IL118178A (en) |
IN (1) | IN185146B (en) |
IS (1) | IS1832B (en) |
MY (1) | MY115018A (en) |
NO (1) | NO309035B1 (en) |
NZ (1) | NZ308249A (en) |
PL (1) | PL184767B1 (en) |
PT (1) | PT828711E (en) |
RU (1) | RU2167153C2 (en) |
SA (1) | SA96160764B1 (en) |
SE (1) | SE9501808D0 (en) |
SK (1) | SK281812B6 (en) |
TR (1) | TR199701362T1 (en) |
TW (1) | TW340841B (en) |
UA (1) | UA46770C2 (en) |
WO (1) | WO1996036606A1 (en) |
ZA (1) | ZA963545B (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1130363C (en) | 1997-11-12 | 2003-12-10 | 三菱化学株式会社 | Purine derivatives and medicine containing the same as the active ingredient |
EP1178046B1 (en) | 1999-05-11 | 2003-11-19 | Mitsubishi Chemical Corporation | Purine derivative dihydrate, drugs containing the same as the active ingredient and intermediate in the production thereof |
AU1037701A (en) * | 1999-10-20 | 2001-04-30 | Smithkline Beecham Plc | Process for the preparation of 4-(fluorophenyl)piperidine esters |
BRPI0104491B8 (en) * | 2001-10-10 | 2021-05-25 | Cristalia Produtos Quim Farmaceuticos Ltda | n-(2,6-dimethylphenyl)-1-propyl-2-piperidinecarboxamide; process of obtaining the enantiomers; non-racemic mixture of anantiomers and its process of obtaining and pharmaceutical composition. |
US20060270708A1 (en) * | 2005-05-25 | 2006-11-30 | Navinta Llc | Novel process for preparation of isotonic aqueous injection of ropivacaine |
WO2009044404A1 (en) * | 2007-10-01 | 2009-04-09 | Ramniwas Goel | Process for the preparation of (s)-ropivacaine hydrochloride monohydrate |
CN102093284B (en) * | 2010-12-29 | 2013-05-08 | 宜昌人福药业有限责任公司 | Method for enriching piperidine-2-formanilide optically active compound |
WO2014009964A1 (en) * | 2012-07-11 | 2014-01-16 | Neon Laboratories Limited | Process for enantiomeric enrichment of 2 ', 6 ' - pipecoloxylidide |
CN103086954A (en) * | 2013-02-04 | 2013-05-08 | 山东省医药工业研究所 | Method for preparing ropivacaine |
CN104003930B (en) * | 2014-06-13 | 2016-06-08 | 山东金诃药物研究开发有限公司 | The preparation method of a kind of hydrochloric acid ropivacaine |
CN113105386B (en) * | 2021-04-10 | 2022-11-25 | 河北一品制药股份有限公司 | Industrialized preparation method of ropivacaine hydrochloride monohydrate |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE341404B (en) * | 1967-05-18 | 1971-12-27 | Sterling Drug Inc | |
EP0151110B1 (en) * | 1983-08-01 | 1989-03-01 | Astra Läkemedel Aktiebolag | L-n-n-propylpipecolic acid-2,6-xylidide and method for preparing the same |
SE451840B (en) * | 1986-01-03 | 1987-11-02 | Astra Laekemedel Ab | OPTICALLY PURE MONOHYDRATED OF S - (-) - 1-PROPYL-2 ', 6'-PIPECOLOXYLIDE HYDROCHLORIDE, SET TO PREPARE THIS AND PHARMACEUTICAL PREPARATIONS FOR LOCAL ANCHORING |
-
1995
- 1995-05-16 SE SE9501808A patent/SE9501808D0/en unknown
-
1996
- 1996-04-19 IN IN837DE1996 patent/IN185146B/en unknown
- 1996-04-30 PT PT96914488T patent/PT828711E/en unknown
- 1996-04-30 DE DE69616543T patent/DE69616543T2/en not_active Expired - Lifetime
- 1996-04-30 CN CN96195279A patent/CN1121388C/en not_active Expired - Lifetime
- 1996-04-30 JP JP08534738A patent/JP3079112B2/en not_active Expired - Lifetime
- 1996-04-30 KR KR1019970708171A patent/KR100425232B1/en active IP Right Grant
- 1996-04-30 TR TR97/01362T patent/TR199701362T1/en unknown
- 1996-04-30 NZ NZ308249A patent/NZ308249A/en not_active IP Right Cessation
- 1996-04-30 AT AT96914488T patent/ATE207900T1/en active
- 1996-04-30 SK SK1512-97A patent/SK281812B6/en not_active IP Right Cessation
- 1996-04-30 CZ CZ19973452A patent/CZ290576B6/en not_active IP Right Cessation
- 1996-04-30 RU RU97120751/04A patent/RU2167153C2/en active
- 1996-04-30 ES ES96914488T patent/ES2166888T3/en not_active Expired - Lifetime
- 1996-04-30 EP EP96914488A patent/EP0828711B1/en not_active Expired - Lifetime
- 1996-04-30 US US08/647,994 patent/US5959112A/en not_active Expired - Lifetime
- 1996-04-30 WO PCT/SE1996/000563 patent/WO1996036606A1/en active IP Right Grant
- 1996-04-30 UA UA97126021A patent/UA46770C2/en unknown
- 1996-04-30 PL PL96323461A patent/PL184767B1/en unknown
- 1996-04-30 CA CA002219308A patent/CA2219308C/en not_active Expired - Fee Related
- 1996-04-30 AU AU57832/96A patent/AU696875B2/en not_active Expired
- 1996-04-30 DK DK96914488T patent/DK0828711T3/en active
- 1996-04-30 EE EE9700301A patent/EE03394B1/en unknown
- 1996-04-30 BR BR9608820A patent/BR9608820A/en not_active Application Discontinuation
- 1996-04-30 HU HU9900327A patent/HU221793B1/en active IP Right Grant
- 1996-05-03 ZA ZA963545A patent/ZA963545B/en unknown
- 1996-05-05 SA SA96160764A patent/SA96160764B1/en unknown
- 1996-05-06 TW TW085105371A patent/TW340841B/en not_active IP Right Cessation
- 1996-05-07 AR ARP960102486A patent/AR002737A1/en unknown
- 1996-05-07 IL IL11817896A patent/IL118178A/en not_active IP Right Cessation
- 1996-05-16 MY MYPI96001857A patent/MY115018A/en unknown
-
1997
- 1997-11-04 IS IS4607A patent/IS1832B/en unknown
- 1997-11-13 NO NO975220A patent/NO309035B1/en not_active IP Right Cessation
-
1998
- 1998-09-17 HK HK98110674A patent/HK1009805A1/en not_active IP Right Cessation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU97120751A (en) | METHOD FOR OBTAINING ROPIVACAININE MONOHYDRATE OF HYDROCHLORIDE AND ROPIVACAINE HYDROCHLORIDE MONOHYDRATE OBTAINED BY THIS METHOD | |
US6258961B1 (en) | Intermediates and process for the preparation thereof | |
RU2007109330A (en) | METHOD FOR PRODUCING IRBESARTAN AND INTERMEDIATE PRODUCTS FOR HIM | |
US6350877B1 (en) | Manufacturing process | |
MY115018A (en) | New process for the preparation of ropivacaine hydrochloride monohydrate | |
JP2009535327A (en) | Ropivacaine hydrochloride anhydride and its preparation | |
EP1397335B1 (en) | Resolution process for (r)-(-)-2-hydroxy-2-(2-chlorophenyl)acetic acid | |
JP2005509011A (en) | Recovery and reuse of chiral tartaric acid resolving agent | |
HU228918B1 (en) | Method for crystallising n-(4-trifluoromethylphenyl)-5-methyl-isoxazole-4-carboxamide | |
CN1214012C (en) | Method for producing carbonyl dimidazoles | |
CZ20023694A3 (en) | Tosylate salts of 4-(p-fluorophenyl)-piperidine-3-methanols | |
EA011763B1 (en) | Processes for preparing venlafaxine hydrochloride of form i | |
US8946433B2 (en) | Process for the preparation of sufentanil base and related compounds | |
RU94043796A (en) | Process for preparing propargyl ammonium chloride | |
EP0035811A1 (en) | Process for resolving DL-S-benzoyl-beta-mercaptoisobutyric acid, and products obtained by applying this process | |
FI64596B (en) | PROCEDURE FOR FRAMSTAELLNING AV 9- (2,6-DIHALOGENBENYL) ADENIN VAESENTLIGEN FRI FRAON 3-ISOMEREN | |
JP2002155058A (en) | Method for producing 1-substituted hydratoin compound | |
JP3316917B2 (en) | New phenylalanine salt crystals and their production | |
TH27327A (en) | New methods for preparing ropiwacken Hydrochloride Monohydrate | |
TH29320B (en) | New methods for preparing ropiwacken Hydrochloride Monohydrate | |
EP1286965B1 (en) | Piperidine compounds and process for providing such | |
RU2220152C2 (en) | Method for preparing n2-[1(s)-carboxy-3-phenylpropyl]-l-lysyl-l-proline | |
JP2912570B2 (en) | Racemization method for aminoketone derivatives | |
US7045630B2 (en) | Method for preparing 4-amino-4-phenylpiperidines | |
RU2000116019A (en) | METHOD FOR PRODUCING N- (1 (S) -CARBOXY-3-Phenylpropyl) -L-Lysyl-L-Proline |